ENDOVENOUS LASER THERAPY MARKET ANALYSIS

Endovenous Laser Therapy Market, by Product Type (Endovenous Laser Systems (Diode Lasers and Yag Lasers) and Endovenous Laser (Fibers Bare Tip Laser Fibers, Radial Tip Laser Fiber and Gold tip Laser Fiber)), By End user (Hospitals, Ambulatory Surgical Centers and Specialty Clinics), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Published In : Jul 2023
Code : CMI3377
Pages :176
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Global Endovenous Laser Therapy Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global endovenous laser therapy market over the forecast period. North America is estimated to hold 42.4 % of the market share in 2023. The North America endovenous laser therapy market is expected to witness significant growth in the coming years, driven by factors such as the inorganic strategies like increasing investment into a companies, Thus, driving the market growth over the forecast period. For instance, in October 2022, Palatine, a private equity firm based in the U.K., announced that it has made a ‘significant investment’ into a Veincentre, a U.K.-based center that provides endovenous laser therapy device for the management of varicose veins.

Major players operating in the global Endovenous Laser Therapymarket include Syneron Medical Ltd., AngioDynamics, Inc., Candela Corporation, Dornier MedTech GmbH, Alma Lasers Ltd., Alna-Medicalsystem GmbH, LSO Medical, Wontech Co., Ltd., Intros Medical Laser GmbH, biolitec AG, EUFOTON S.R.L , Teleflex Incorporated, Boston Scientific Corporation, Merit Medical Systems, Sciton, Inc. and Energist Ltd.